Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Zanzalintinib and Pembrolizumab in First-Line Maintenance for Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Apply
Zanzalintinib & Pembrolizumab
Zanzalintinib and Pembrolizumab in First-Line Maintenance for Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step